Avalo Therapeutics AVTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$19.63M-43.1% | -$13.72M+55.2% | -$30.63M-47.5% | -$20.77M-57.9% | -$13.15M+62.8% | ||
| $17K+6.3% | $16K-72.9% | $59K-56.0% | $134K-0.7% | $135K+98.5% | ||
| $3.58M-20.7% | $4.51M+42.9% | $3.15M+16.0% | $2.72M-16.1% | $3.24M+11.6% | ||
| -$17.69M-24.2% | -$14.25M+12.9% | -$16.37M-43.7% | -$11.39M-20.4% | -$9.46M+37.1% | ||
| $25.51M— | $0+100% | -$13.26M+81.3% | -$70.86M— | $0— | ||
| $1.4M+104% | $687K-95.2% | $14.37M+3,164% | -$469K— | $0-100% | ||
| $9.21M+183% | -$11.16M+26.9% | -$15.26M+81.6% | -$82.72M-775% | -$9.46M-118% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Avalo Therapeutics generate?
- Avalo Therapeutics (AVTX) generated -$59.7M in operating cash flow over the trailing twelve months.
- Where does Avalo Therapeutics's cash flow data come from?
- Every line is extracted from Avalo Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
